BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/21/2021 9:30:52 AM | Browse: 16 | Download: 20
Publication Name World Journal of Clinical Oncology
Manuscript ID 64954
Country/Territory Argentina
Received
2021-02-25 17:21
Peer-Review Started
2021-02-25 17:30
To Make the First Decision
Return for Revision
2021-05-04 02:36
Revised
2021-05-10 22:12
Second Decision
2021-06-25 13:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-06-25 14:16
Articles in Press
2021-06-25 14:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-07-01 20:06
Typeset the Manuscript
2021-07-19 07:07
Publish the Manuscript Online
2021-07-21 09:30
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?
Manuscript Source Invited Manuscript
All Author List Francisco Laxague and Francisco Schlottmann
ORCID
Author(s) ORCID Number
Francisco Laxague http://orcid.org/000-0002-3140-883X
Francisco Schlottmann http://orcid.org/0000-0003-3565-0559
Funding Agency and Grant Number
Corresponding Author Francisco Schlottmann, MD, Surgeon, Department of Surgery, Hospital Alemán of Buenos Aires, Av. Pueyrredón 1640, Buenos Aires 1118, Argentina. fschlottmann@hotmail.com
Key Words Esophageal cancer; Esophagogastric junction tumor; Esophageal Adenocarcinoma; Chemotherapy; Chemoradiation; Neoadjuvant therapy.
Core Tip Surgical treatment only has shown poor results in patients with locally advanced esophagogastric junction tumors. Perioperative chemotherapy and neoadjuvant chemoradiation are valid treatment modalities for these patients. This evidence-based review explores the results, advantages, and disadvantages of both approaches. In addition, future directions with potentially effective novel drugs are also discussed.
Publish Date 2021-07-21 09:30
Citation Laxague F, Schlottmann F. Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy? World J Clin Oncol 2021; 12(7): 557-564
URL https://www.wjgnet.com/2218-4333/full/v12/i7/557.htm
DOI https://dx.doi.org/10.5306/wjco.v12.i7.557
Full Article (PDF) WJCO-12-557.pdf
Full Article (Word) WJCO-12-557.docx
Manuscript File 64954_Review-FilipodiaCL.docx
Answering Reviewers 64954-Answering reviewers.pdf
Audio Core Tip 64954-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 64954-Conflict-of-interest statement.pdf
Copyright License Agreement 64954-Copyright license agreement.pdf
Peer-review Report 64954-Peer-review(s).pdf
Scientific Misconduct Check 64954-Scientific misconduct check.pdf
Scientific Editor Work List 64954-Scientific editor work list.pdf